+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Proteomics Market by Component and Application: Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4828945
  • Report
  • 225 pages
  • Allied Analytics LLP
1 of 4
The global proteomics market was valued at $24,361million in 2017, and is expected to reach $72,444 million by 2025, growing at a CAGR of 14.5% during the forecast period. Proteomics is the study of the structure and functions of proteins. It is a complex study as compared to genomics, as genomes are constant, while proteomes differ depending on the cells and time.
The global proteomics market has witnessed significant growth over the past few years, owing to increased utility of proteomics in the diagnosis of diseases and identification of potential new drugs for the treatment of various diseases. Factors such as rise in focus of key players toward product development, surge in R&D expenditure on proteomics, increase in popularity for personalized medicines, and technological advancements in proteomics are expected to drive the market. However, stringent regulatory approvals, high cost of instruments, and dearth of qualified researchers are expected to hamper the market growth.
The global proteomics market is segmented based on component, application, and region. On the basis of component, the market is categorized into reagents, instruments, and services. The reagents segment is further classified into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is subsegmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry.
Likewise, the chromatography segment is subclassified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography. The applications covered in the study include drug discovery, disease diagnosis, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key companies profiled in the report include Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation. The other players included in the value chain analysis (but not included in the report) are Becton, Dickinson and Company, Caprion Biosciences, and others.

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the global proteomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis for the period of 2017–2025 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market by components helps to understand the various types of instruments used across geographies.
  • Comprehensive analysis of all regions is provided to determine the prevailing opportunities in these regions.
  • Key market players have been profiled in the report and their strategies have been analyzed thoroughly to understand the competitive outlook of the global market.
  • Extensive analysis of the market is conducted by closely following key product positioning, and monitoring the top contenders within the market framework.
Key Market Segments

By Component
  • Instruments
o Microarray
o Spectrometry
  • Mass Spectrometry
  • NMR Spectrometry
o X-ray Crystallography
o Chromatography
  • HPLC Systems
  • Ion Chromatography
  • Affinity Chromatography
  • Supercritical Fluid Chromatography
o Electrophoresis
o Surface Plasmon Resonance
o Protein Fractionation Reagents
  • Reagents
o Microarray
o Spectroscopy
o X-ray Crystallography
o Chromatography
o Electrophoresis
o Immunoassay
o Protein Fractionation Reagents
  • Services
By Application
  • Drug Discovery
  • Disease Diagnosis
  • Others
By Region
  • North America
o U.S.
o Canada
o Mexico
  • Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
  • Asia-Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific
  • LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
Note: Product cover images may vary from those shown
2 of 4
Chapter 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective

Chapter 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Top player positioning
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in popularity of personalized medicines
3.4.1.2. Upsurge in R&D expenditure
3.4.1.3. Technological advancements associated with proteomics components
3.4.2. Restraints
3.4.2.1. High costs associated with proteomics components
3.4.2.2. Dearth of skilled professionals
3.4.3. Opportunities
3.4.3.1. Lucrative opportunities associated with biomarker identification
3.4.3.2. Developments in mass spectrometry-based proteomics

Chapter 4: PROTEOMICS MARKET, BY COMPONENT
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Microarray
4.2.3.1. Market size and forecast
4.2.4. Spectrometry
4.2.4.1. Market size and forecast
4.2.5. X-ray crystallography
4.2.5.1. Market size and forecast
4.2.6. Chromatography
4.2.6.1. Market size and forecast
4.2.7. Electrophoresis
4.2.7.1. Market size and forecast
4.2.8. Immunoassay
4.2.8.1. Market size and forecast
4.2.9. Protein fractionation reagents
4.2.9.1. Market size and forecast
4.2.10. Market analysis, by country
4.3. Instruments
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Microarray
4.3.3.1. Market size and forecast
4.3.4. Spectrometry
4.3.4.1. Market size and forecast
4.3.4.1.1. Mass spectrometry
4.3.4.1.1.1. Market size and forecast
4.3.4.1.2. NMR spectrometry
4.3.4.1.2.1. Market size and forecast
4.3.5. Chromatography
4.3.5.1. Market size and forecast
4.3.5.1.1. HPLC systems
4.3.5.1.1.1. Market size and forecast
4.3.5.1.2. Ion chromatography
4.3.5.1.2.1. Market size and forecast
4.3.5.1.3. Affinity chromatography
4.3.5.1.3.1. Market size and forecast
4.3.5.1.4. Supercritical fluid chromatography
4.3.5.1.4.1. Market size and forecast
4.3.6. Electrophoresis
4.3.6.1. Market size and forecast
4.3.7. Surface plasmon resonance
4.3.7.1. Market size and forecast
4.3.8. X-ray crystallography
4.3.8.1. Market size and forecast
4.3.9. Protein fractionation systems
4.3.9.1. Market size and forecast
4.3.10. Market analysis, by country
4.4. Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

Chapter 5: PROTEOMICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Drug discovery
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Disease diagnosis
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast
5.4.2. Market analysis, by country

Chapter 6: PROTEOMICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. proteomics market, by component
6.2.2.1.2. U.S. proteomics market, by application
6.2.2.2. Canada
6.2.2.2.1. Canada proteomics market, by component
6.2.2.2.2. Canada proteomics market, by application
6.2.2.3. Mexico
6.2.2.3.1. Mexico proteomics market, by component
6.2.2.3.2. Mexico proteomics market, by application
6.2.3. North America proteomics market, by component
6.2.4. North America proteomics market, by application
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany proteomics market, by component
6.3.2.1.2. Germany proteomics market, by application
6.3.2.2. France
6.3.2.2.1. France proteomics market, by component
6.3.2.2.2. France proteomics market, by application
6.3.2.3. UK
6.3.2.3.1. UK proteomics market, by component
6.3.2.3.2. UK proteomics market, by application
6.3.2.4. Italy
6.3.2.4.1. Italy proteomics market, by component
6.3.2.4.2. ITALY proteomics market, by application
6.3.2.5. Spain
6.3.2.5.1. Spain proteomics market, by component
6.3.2.5.2. Spain proteomics market, by application
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe proteomics market, by component
6.3.2.6.2. Rest of Europe proteomics market, by application
6.3.3. Europe proteomics market, by component
6.3.4. Europe proteomics market, by application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.1.1. Japan
6.4.1.1.1. Japan proteomics market, by component
6.4.1.1.2. Japan proteomics market, by application
6.4.1.2. China
6.4.1.2.1. China proteomics market, by component
6.4.1.2.2. China proteomics market, by application
6.4.1.3. India
6.4.1.3.1. India proteomics market, by component
6.4.1.3.2. India proteomics market, by application
6.4.1.4. Australia
6.4.1.4.1. Australia proteomics market, by component
6.4.1.4.2. Australia proteomics market, by application
6.4.1.5. South Korea
6.4.1.5.1. South Korea proteomics market, by component
6.4.1.5.2. South Korea proteomics market, by application
6.4.1.6. Rest of Asia-Pacific
6.4.1.6.1. Rest of Asia-Pacific proteomics market, by component
6.4.1.6.2. Rest of Asia-Pacific proteomics market, by application
6.4.2. Asia-Pacific proteomics market, by component
6.4.3. Asia-Pacific proteomics market, by application
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil proteomics market, by component
6.5.2.1.2. Brazil proteomics market, by application
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia proteomics market, by component
6.5.2.2.2. Saudi Arabia proteomics market, by application
6.5.2.3. South Africa
6.5.2.3.1. South Africa proteomics market, by component
6.5.2.3.2. South Africa proteomics market, by application
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA proteomics market, by component
6.5.2.4.2. Rest of LAMEA proteomics market, by application
6.5.3. LAMEA proteomics market, by component
6.5.4. LAMEA proteomics market, by application

Chapter 7: COMPANY PROFILES
7.1. AGILENT TECHNOLOGIES, INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. DANAHER CORPORATION (BECKMAN COULTER, INC.)
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. LI-COR, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.4. PERKINELMER INC.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. THERMO FISHER SCIENTIFIC, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. HORIBA, LTD.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. BIO-RAD LABORATORIES, INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product type Portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. BRUKER CORPORATION (BECKMAN COULTER, INC.)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product type portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. GE HEALTHCARE (GENERAL ELECTRIC)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.10. WATERS CORPORATION (BECKMAN COULTER, INC.)
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product type portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

*Full List of Tables and Figures Available on Enquiry.

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to this report titled, 'Global Proteomics Market by Component, Application: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,' the global proteomics market was valued at $24,361 million in 2017, and is projected to reach $72,444 million by 2025, growing at a CAGR of 14.5% from 2018 to 2025. The instruments segment is expected to dominate the global market throughout the forecast period. North America held the leading position in the global market in 2017, and is expected to maintain this trend until 2025.

Proteomics is the study of proteins, particularly their function and structure on a large scale. It is a remarkable approach for studying dynamic changes in metabolism in response to diverse stress conditions. The key drivers of the global proteomics market include increased R&D funding by leading players and government agencies, such as National Institutes of Health (NIH) and National Science Foundation (NSF), technological advancements, such as development of dual mass analyzers (for instance LC/MS, GC/MS, FT-MS, and MALDI-TOF/TOF), and improvements in the liquid chromatography & gel electrophoresis procedures. Moreover, increase in popularity of personalized medicines is expected to propel the proteomics market growth. However, high cost of instruments and dearth of skilled researchers hamper the market growth.

The global proteomics market is segmented based on component, application, and region. On the basis of component, the market is categorized into reagents, instruments, and services. The reagents segment is further classified into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is subsegmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry. Likewise, the chromatography segment is subclassified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography. The applications covered in the study include drug discovery, disease diagnosis, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Protein microarray segment generated the highest revenue in 2017 in the proteomics instruments market, owing to high usage of this technology to track protein interactions in lesser time as compared to other technologies. The immunoassays segment was the highest revenue generator 2017, as immunoassays are extensively utilized in primary screening in drug discovery and microarray technologies. On the basis of application, the drug discovery segment garnered the majority share in 2017, owing to increase in awareness of personalized medicines in both emerging and developed markets.

The major players involved in the global proteomics industry have adopted different key developmental strategies such as product development, acquisition, and collaboration to sustain the competition in the industry. For instance, in June 2018, Bruker Corporation introduced a broad line of mass spectrometry products and workflows at the ASMS (American Society for Mass Spectrometry) conference. Likewise, in March 2017, ThermoFisher Scientific, Inc. launched iXR Raman Spectrometer, which was multi-modal, enabled simultaneous measurements. This new product was designed for rapid and accurate chemical and structural analysis. Furthermore, in January 2019, Waters Corporation introduced the BioAccord System, a liquid chromatography-mass spectrometry (LC-MS) solution that is anticipated to expand access to high-resolution time-of-flight mass spectrometry capabilities to more scientists.

The key proteomics industry companies profiled in the report include Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation. The other players included in the value chain analysis (but not included in the report) are Becton, Dickinson and Company, Caprion Biosciences and others.

Key Findings of the Proteomics Market:

The reagents segment generated the highest revenue in 2017, and is projected to grow at a CAGR of 14.0% during the forecast period.
The instruments segment is anticipated to grow at the highest CAGR throughout the forecast period.
Drug discovery application dominated the global proteomics market share in 2017, accounting for nearly three-fifths of the proteomics market size in 2017.
In 2017, the U.S. was the leading country, occupying the largest market share in the global proteomics market.

North America held the largest proteomics market size of nearly two-fifths share of the total market in 2017, due to increase in popularity and adoption of personalized medicines and favorable government funding & initiatives to develop novel therapeutics. However, Asia-Pacific is expected to grow at a CAGR of 16.8% from 2018 to 2025, owing to rise in prevalence of chronic diseases and increase in interest of researchers to utilize proteomics in disease diagnosis & treatment.
Note: Product cover images may vary from those shown
5 of 4

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll